America's Car-Mart Stock (NASDAQ:CRMT), Trade Ideas

America's Car-Mart

America's Car-Mart Inc is an automotive retailer in us focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The Company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It primarily sells older model used vehicles and provides financing for substantially all of its customers. The Company earns revenue from the sale of used vehicles and in most cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

Long Ideas

News

Small Cap

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

AUID

CRMT

Although U.S. stocks closed lower on Monday, there were a few notable insider trades.

Insiders Buying Walgreens And 2 Other Stocks

TRDA

Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.

Insiders Buying America&#39;s Car-Mart And 2 Other Stocks

Equities

Movers

General

America&#39;s Car-Mart reports wider-than-expected Q3 loss with lower revenue, sales volume, partially offset by higher average retail sales price.

What&#39;s Going With America&#39;s Car-Mart Shares Today?

America's Car-Mart Inc

Although U.S. stocks closed lower on Monday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#39;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Walgreens Boots Alliance </h3>
<ul>
<li>The Trade: Walgreens Boots Alliance, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wba#NASDAQ">WBA</a>) Director Inderpal S Bhandari <a href="https://www.benzinga.com/quote/WBA/analyst-ratings"> acquired a total of 3,000 shares </a> an average price of $18.05. To acquire these shares, it cost around $54,150..</li>
<li>What&rsquo;s Happening: On March 28, Walgreens reported better than expected second-quarter earnings and tightened FY24 guidance.</li>
<li>What Walgreens Does: Walgreens Boots Alliance is one of the largest retail pharmacy chains in the U.S., with over 8,500 locations.</li>
</ul>
<h3>authID </h3>
<ul>
<li>The Trade: authID Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auid#NASDAQ">AUID</a>) 10% owner Stephen Jeffrey Garchik acquired a total of 10,500 shares at an average price of $7.69. To acquire these shares, it cost around $80,745.</li>
<li>What&rsquo;s Happening: On March 20, authID posted a narrower FY23 loss.</li>
<li>What authID Does: AuthID Inc is a company engaged in ensuring cyber-savvy enterprises &quot;Know Who&#39;s Behind the Device&quot; for every customer or employee login and transaction.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<h3>America&#39;s Car-Mart </h3>
<ul>
<li>The Trade: America&#39;s Car-Mart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crmt#NASDAQ">CRMT</a>) 10% owner Magnolia Group, LLC <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 13,550 shares </a> at an average price of $57.87. To acquire these shares, it cost around $784,139.</li>
<li>What&rsquo;s Happening: On April 10, B of A Securities analyst John Murphy maintained America&#39;s Car-Mart with an Underperform and lowered the price target from $55 to $50.</li>
<li>What America&#39;s Car-Mart Does: America&#39;s Car-Mart Inc is an automotive retailer in us focused exclusively on the Integrated Auto Sales and Finance segment of the used car market.</li>
</ul>
&nbsp;
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/04/38263377/fear-greed-index-moves-to-fear-zone-s-p-500-down-over-1"> Fear &amp; Greed Index Moves To &#39;Fear&#39; Zone; S&amp;P 500 Down Over 1% </a>
&nbsp;

Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#39;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>HCI Group </h3>
<ul>
<li>The Trade: HCI Group Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hci#NYSE">HCI</a>) CEO Paresh Patel <a href="https://www.benzinga.com/quote/HCI/analyst-ratings"> acquired a total of 1,000 shares </a> an average price of $114.90. To acquire these shares, it cost around $114,900.</li>
<li>What&rsquo;s Happening: Oppenheimer analyst Michael Phillips maintained HCI Group with an Outperform and maintained a $140 price target.</li>
<li>What HCI Group Does: HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property &amp; Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap).</li>
</ul>
<h3>America&#39;s Car-Mart </h3>
<ul>
<li>The Trade: America&#39;s Car-Mart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crmt#NASDAQ">CRMT</a>) President and CEO Douglas W.. Campbell Jr acquired a total of 3,229 shares at an average price of</li>
<li>$61.62. To acquire these shares, it cost around $198,985.</li>
<li>What&rsquo;s Happening: On April 10, B of A Securities analyst John Murphy maintained America&#39;s Car-Mart with an Underperform and lowered the price target from $55 to $50.</li>
<li>What America&#39;s Car-Mart Does: America&#39;s Car-Mart Inc is an automotive retailer in us focused exclusively on the Integrated Auto Sales and Finance segment of the used car market.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<h3>Entrada Therapeutics </h3>
<ul>
<li>The Trade: Entrada Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trda#NASDAQ">TRDA</a>) Director Peter S Kim <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 2,600 shares </a> at an average price of $13.57. To acquire these shares, it cost around $35,290.</li>
<li>What&rsquo;s Happening: On March 13, Entrada Therapeutics posted upbeat quarterly sales.</li>
<li>What Entrada Therapeutics Does: Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38176505/jim-cramer-says-wesco-international-is-a-buy-recommends-buying-this-stock-under-20"> Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20 </a>

Insiders Buying America's Car-Mart And 2 Other Stocks

WIIM

IRBT

LESL

RVLV

SNBR

WOOF

Shares of retail companies are trading lower amid overall market weakness following hotter-than-expected March inflation data.

B of A Securities analyst John Murphy maintains America's Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) with a Underperform and lowers the price target from $55 to $50.

Price Target

Analyst Ratings

B of A Securities Maintains Underperform on America's Car-Mart, Lowers Price Target to $50

America&#8217;s Car-Mart, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) shares are trading higher on Friday. The company reported third-quarter FY24 earnings of a $(1.34) loss, <a href="https://www.benzinga.com/pressreleases/24/03/g37557220/americas-car-mart-reports-third-quarter-fiscal-2024-results" target="_blank" rel="noreferrer noopener">wider than the analyst consensus for a $(0.65) loss. </a>
America&#8217;s Car-Mart registered quarterly revenue of $299.61 million,<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">&nbsp;missing the analyst consensus of $350.95 million.</a>
Third-quarter sales fell 7.9% due to decreased retail units sold, while total collections increased 9.3%. A portion of the decline in revenue was masked by the average retail sales price being up 7.5%.
Sales for the quarter were 11,664 units versus 14,508 units, down 19.6% compared to the prior-year quarter. 
Total credit application volume was down 8.3% year over year, which represented about half of the sales decline.
Allowance for credit loss in the quarter under review adjusted to 25.74%,<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">&nbsp;down sequentially 30 bps</a>.
&#8220;While sales volumes fell short of our expectations during the quarter, they are not reflective of the efforts put forth by the team,&#8221; said Doug Campbell President and CEO.&nbsp;
&#8220;We have implemented several initiatives to improve sales during the fourth quarter. Our priority is to be agile with our cost structure and investments to deliver long-term profitability and shareholder value,&#8221; added Campbell.
In February, the Company entered into a strategic partnership with Cox Automotive which is expected to drive better outcomes regarding vehicle acquisition, reconditioning, transportation, and remarketing activities.&nbsp;
Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/03/37560669/taiwan-semiconductor-manufacturing-stock-is-up-over-5-whats-going-on" rel="noreferrer noopener">Taiwan Semiconductor Manufacturing Stock Is Up Over 5% &#8211; What&#8217;s Going On?</a>
Price Action:&nbsp;CRMT shares are trading higher by 4.11% to $64.86 on the last check Friday.

What's Going With America's Car-Mart Shares Today?

Shares of Marvell Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrvl#NASDAQ">MRVL</a>) fell sharply during Friday&rsquo;s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.
Marvell said fourth-quarter revenue increased 1% year-over-year to $1.427 billion, which beat the consensus estimate of $1.42 billion. The chip designer reported quarterly earnings of 46 cents per share, which was in line with analyst estimates.
Marvell sees first-quarter revenue of $1.15 billion, plus or minus 5%, versus estimates of $1.371 billion. The company sees first-quarter adjusted earnings of 23 cents per share, plus or minus 5 cents per share, versus estimates of 40 cents per share. The company authorized a $3 billion buyback.
Marvell Technology shares dipped 9.6% to $76.91 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
Ainos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aimd#NASDAQ">AIMD</a>) jumped 140% to $2.6899 after dipping 18% on Thursday.
Psyence Biomedical Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbm#NASDAQ">PBM</a>) shares climbed 139% to $3.0350. Psyence Biomedical recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study.
Safe and Green Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgd#NASDAQ">SGD</a>) shares jumped 138% to $1.57 after the company announced financing for the Norman Berry Expansion in Atlanta, Georgia.
MIRA Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mira#NASDAQ">MIRA</a>) shares climbed 48.5% to $1.36. MIRA Pharmaceuticals, last month, announced a research collaboration with Pharmaseed to research and evaluate Ketamir for patients with major depressive disorder and post-traumatic stress disorder.
CERo Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cero#NASDAQ">CERO</a>) shares climbed 35.4% to $4.17 after surging over 20% on Thursday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients.
Willdan Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wldn#NASDAQ">WLDN</a>) gained 30.4% to $25.89 after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance above estimates. Also, the company secured a contract worth approximately $30 million to $50 million over three years.
The Joint Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jynt#NASDAQ">JYNT</a>) gained 29% to $11.80 following fourth-quarter results.
Smith &amp; Wesson Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swbi#NASDAQ">SWBI</a>) jumped 25.8% to $16.91 after the company reported better-than-expected third-quarter financial results.
Research Frontiers Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/refr#NASDAQ">REFR</a>) climbed 25.6% to $1.42 following fourth-quarter results.
Gulf Island Fabrication, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gifi#NASDAQ">GIFI</a>) shares gained 24.1% to $6.43 after the company reported a year-over-year increase in fourth-quarter revenue results.
Grifols, S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grfs#NASDAQ">GRFS</a>) gained 22.7% to $6.89 after the company announced it published its consolidated annual accounts for 2023.
DoubleDown Interactive Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ddi#NASDAQ">DDI</a>) gained 21.6% to $14.25.
Dogness (International) Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dogz#NASDAQ">DOGZ</a>) gained 18.6% to $7.98.
Kidpik Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pik#NASDAQ">PIK</a>) gained 18.3% to $3.0177.
America&#39;s Car-Mart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crmt#NASDAQ">CRMT</a>) jumped 16.5% to $72.56 following third-quarter results.
Porch Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prch#NASDAQ">PRCH</a>) rose 16.1% to $3.6099 after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance.
Samsara Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iot#NYSE">IOT</a>) gained 14.3% to $39.28 after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance above estimates.
Viracta Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/virx#NASDAQ">VIRX</a>) shares gained 13.5% to $0.9200 following fourth-quarter results.
Aeva Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aeva#NASDAQ">AEVA</a>) rose 12.6% to $1.34.
Adaptimmune Therapeutics plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adap#NASDAQ">ADAP</a>) gained 12.1% to $1.95. Adaptimmune Therapeutics recently reported better-than-expected quarterly EPS results.
HCI Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hci#NYSE">HCI</a>) gained 11.3% to $110.42 after the company reported better-than-expected fourth-quarter financial results.
NuScale Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) jumped 10.5% to $4.9289.
Redfin Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdfn#NASDAQ">RDFN</a>) jumped 9.6% to $7.10.
reAlpha Tech Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aire#NASDAQ">AIRE</a>) rose 8.8% to $1.3599. reAlpha Tech, last month, appointed Michael Frenz as CFO and Mike Logozzo as President and COO.
Carnival Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccl#NYSE">CCL</a>) gained 5% to $16.44.
<h3>Losers</h3>
Amylyx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amlx#NASDAQ">AMLX</a>) shares fell 80.7% to $3.6596 after the company announced its PHOENIX phase 3 trial of AMX0035 for amyotrophic lateral sclerosis did not meet its primary endpoint and there was no statistical significance seen in secondary endpoints.
BigBear.ai Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbai#NYSE">BBAI</a>) fell 30.8% to $2.6006 after the company reported worse-than-expected fourth-quarter financial results.
Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) tumbled 28.6% to $0.0819.
Critical Metals Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crml#NASDAQ">CRML</a>) fell 27.7% to $7.95.
Swvl Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) fell 26.3% to $5.45.
Immuron Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrn#NASDAQ">IMRN</a>) shares dipped 24.7% to $3.4250 after jumping 161% on Thursday.
AerSale Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asle#NASDAQ">ASLE</a>) fell 24.4% to $7.11 after the company reported worse-than-expected fourth-quarter financial results.
CarParts.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prts#NASDAQ">PRTS</a>) fell 24.3% to $1.8999 following fourth-quarter results.
Mobix Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mobx#NASDAQ">MOBX</a>) fell 20.1% to $1.39.
Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) fell 19% to $0.8001 after surging 28% on Thursday. Nxu recently announced it successfully charged a Tesla Cybertruck.
Brera Holdings PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brea#NASDAQ">BREA</a>) shares fell 16.9% to $1.62. Brera Holdings shares jumped 91% on Thursday after the company announced that its Executive Chairman, Daniel McClory, acquired a majority stake in the company. 
Custom Truck One Source, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctos#NYSE">CTOS</a>) dipped 15.3% to $5.26 after the company reported mixed quarterly financial results.
Nexalin Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxl#NASDAQ">NXL</a>) fell 15.1% to $0.4627. Nexalin Technology recently announced results of a clinical study of its Gen-2 tACS device for the treatment of chronic insomnia.
Runway Growth Finance Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rway#NASDAQ">RWAY</a>) fell 13.5% to $11.68 following downbeat quarterly results.
Domo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/domo#NASDAQ">DOMO</a>) fell 12.7% to $9.92 after the company issued soft first-quarter and FY25 guidance.
MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) declined 12.4% to $19.05 after the company announced a secondary offering of 3 million shares.
Genesco Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gco#NYSE">GCO</a>) fell 11.7% to $25.84 after the company&#39;s reported a fourth-quarter EPS miss and issued weak FY25 guidance.
Delek Logistics Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dkl#NYSE">DKL</a>) fell 11.3% to $39.51 after the company priced a public offering of 3,116,884 common units at $38.50 per unit.
Grom Social Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grom#NASDAQ">GROM</a>) fell 11% to $1.13 after jumping 65% on Thursday. The company announced that it entered into a non-binding letter of intent to acquire Arctic7.
Traeger, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cook#NYSE">COOK</a>) fell 10.5% to $2.11 after the company reported worse-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance below estimates.
Aquestive Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aqst#NASDAQ">AQST</a>) dipped 10% to $5.11 following fourth-quarter results.
Petr&oacute;leo Brasileiro S.A. - Petrobras (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pbr#NYSE">PBR</a>) shares fell 9.6% to $15.10 as the company reported a 6.3% year-over-year decline in its fourth-quarter net recurring profit.
Costco Wholesale Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cost#NASDAQ">COST</a>) fell 7.5% to $727.08 following mixed second-quarter results.
MongoDB, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdb#NASDAQ">MDB</a>) declined 6.4% to $385.82 after the company issued weak FY25 guidance.
Icahn Enterprises L.P. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iep#NASDAQ">IEP</a>) fell 4.7% to $17.85.
RadNet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdnt#NASDAQ">RDNT</a>) dipped 4.1% to $46.54. RadNet priced its public offering of 4.55 million common stock at $44 per share.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37553898/cramer-says-sprout-social-is-in-a-hot-spot-but-this-energy-stock-is-too-down-and-out"> Cramer Says Sprout Social Is In A &#39;Hot Spot,&#39; But This Energy Stock Is &#39;Too Down And Out&#39; </a>

Penny Stocks

Intraday Update

ADAP

AEVA

AIMD

AIRE

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

AQST

ASLE

BBAI

BREA

CERO

COOK

COST

CRML

CTOS

DOGZ

DOMO

EGOX

GIFI

GRFS

GROM

IMRN

JYNT

MIRA

MOBX

MRVL

PRCH

PRTS

RDFN

RDNT

REFR

RWAY

SWBI

SWVL

VIRX

WLDN

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

America's Car-Mart shares are trading higher after the company reported Q3 financial results.

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Friday.
Shares of Smith &amp; Wesson Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swbi#NASDAQ">SWBI</a>) rose sharply during Friday&rsquo;s session after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/03/37559530/why-firearm-maker-smith-wessons-shares-are-shooting-higher-today">third-quarter financial results</a>.
The company recorded sales growth of 6.5% year-on-year to $137.5 million, beating the analyst consensus estimate of $133.55 million. Adjusted EPS of $0.19 beat the consensus estimate of $0.10.
Smith &amp; Wesson Brands shares surged 25.8% to $16.91 on Friday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Willdan Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wldn#NASDAQ">WLDN</a>) jumped 30.4% to $25.89 after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance above estimates. Also, the company secured a contract worth approximately $30 million to $50 million over three years.</li>
<li>Gulf Island Fabrication, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gifi#NASDAQ">GIFI</a>) shares rose 24.1% to $6.43 after the company reported a year-over-year increase in fourth-quarter revenue results.</li>
<li>Grifols, S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grfs#NASDAQ">GRFS</a>) climbed 22.7% to $6.89 after the company announced it published its consolidated annual accounts for 2023.</li>
<li>DoubleDown Interactive Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ddi#NASDAQ">DDI</a>) climbed 21.6% to $14.25.</li>
<li>America&#39;s Car-Mart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crmt#NASDAQ">CRMT</a>) rose 16.5% to $72.56 following third-quarter results.</li>
<li>Porch Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prch#NASDAQ">PRCH</a>) gained 16.1% to $3.6099 after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance.</li>
<li>Samsara Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iot#NYSE">IOT</a>) climbed 14.3% to $39.28 after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance above estimates.</li>
<li>PureCycle Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pct#NASDAQ">PCT</a>) gained 12.7% to $5.75.</li>
<li>Carvana Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) gained 12.2% to $89.19 after RBC Capital upgraded the stock from Underperform to Sector Perform and raised its price target from $45 to $90.</li>
<li>Adaptimmune Therapeutics plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adap#NASDAQ">ADAP</a>) rose 12.1% to $1.95. Adaptimmune Therapeutics recently reported better-than-expected quarterly EPS results.</li>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) gained 11.6% to $11.31. Ventyx Biosciences recently announced a $100 million private placement of common stock.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) gained 11.6% to $19.88.</li>
<li>HCI Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hci#NYSE">HCI</a>) climbed 11.3% to $110.42 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) rose 10.5% to $24.10.</li>
<li>Valneva SE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/valn#NASDAQ">VALN</a>) gained 10.2% to $7.58.</li>
<li>Redfin Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdfn#NASDAQ">RDFN</a>) gained 9.6% to $7.10.</li>
<li>Plug Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>) rose 8.5% to $4.2350.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) climbed 8.4% to $39.65.</li>
<li>Upstart Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upst#NASDAQ">UPST</a>) climbed 8.2% to $28.53.</li>
<li>Riot Platforms, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) gained 6.8% to $12.79.</li>
<li>Snap Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snap#NYSE">SNAP</a>) rose 6% to $12.56 after the House Energy and Commerce Committee unanimously approved a bill that that would force ByteDance to divest TikTok.</li>
<li>Carnival Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccl#NYSE">CCL</a>) rose 5% to $16.44.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/03/37557834/cisco-robinhood-and-2-other-stocks-insiders-are-selling"> Cisco, Robinhood And 2 Other Stocks Insiders Are Selling </a>

AFRM

CLSK

CVNA

MARA

PLUG

RIOT

SNAP

UPST

VALN

VTYX

Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday

America's Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) reported quarterly losses of $(1.34) per share which missed the analyst consensus estimate of $(0.65) by 106.15 percent. This is a 682.61 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $299.61 million which missed the analyst consensus estimate of $350.95 million by 14.63 percent. This is a 8.24 percent decrease over sales of $326.53 million the same period last year.

Earnings

America's Car-Mart Q3 EPS $(1.34) Misses $(0.65) Estimate, Sales $299.61M Miss $350.95M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; Algonquin Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AQN#NYSE">AQN</a>) is likely to report quarterly earnings at $0.14 per share on revenue of $743.00 million.
&bull; Lazydays Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) is likely to report quarterly loss at $0.66 per share on revenue of $228.02 million.
&bull; Genesco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCO#NYSE">GCO</a>) is likely to report quarterly earnings at $3.04 per share on revenue of $705.66 million.
&bull; Dixie Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXYN#NASDAQ">DXYN</a>) is estimated to report earnings for its fourth quarter.
&bull; Petroleo Brasileiro S.A.- Petrobras American Depositary Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBR#NYSE">PBR</a>) is expected to report quarterly earnings at $1.03 per share on revenue of $26.90 billion.
&bull; Petrobras Brasileiro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBR#NYSE">PBR</a>) is likely to report quarterly earnings at $1.11 per share on revenue of $26.94 billion.
&bull; America&#39;s Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) is expected to report quarterly loss at $0.65 per share on revenue of $350.95 million.
&bull; Bio-Path Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) is projected to report earnings for its fourth quarter.
<h3>Companies Reporting After The Bell</h3>
&bull; Central Puerto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CEPU#NYSE">CEPU</a>) is likely to report quarterly earnings at $0.01 per share on revenue of $114.11 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

BPTH

CEPU

DXYN

GORV

Earnings Scheduled For March 8, 2024

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, with the index moving to the &quot;Extreme Greed&quot; zone on Thursday.
U.S. stocks closed higher on Thursday, with the S&amp;P 500 surging to a record high level during the session.
Addressing the Senate Banking Committee, Fed Chair Jerome Powell indicated that the Fed is not too far from being confident enough to cut rates, suggesting a growing inclination among policymakers to initiate easing policy this year.
Kroger Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kr#NYSE">KR</a>) reported better-than-expected earnings for its fourth quarter. BJ&rsquo;s Wholesale Club Holdings Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bj#NYSE">BJ</a>) reported downbeat sales for its fourth quarter.
On the economic data front, U.S. initial jobless claims came in unchanged at 217,000 in the latest week, higher than market estimates of 215,000. The U.S. reported a trade gap of $67.4 billion in January compared to revised $63.5 billion gap in the prior month.
Most sectors on the S&amp;P 500 closed on a positive note, with information technology, communication services, and materials stocks recording the biggest gains on Thursday. However, financial and real estate stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by over 130 points to 38,791.35 on Thursday. The S&amp;P 500 rose 1.03% at 5,157.36, while the Nasdaq Composite rose 1.51% at 16,273.38 during Thursday&rsquo;s session.
Investors are awaiting earnings results from Algonquin Power &amp; Utilities Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aqn#NYSE">AQN</a>), America&#39;s Car-Mart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crmt#NASDAQ">CRMT</a>) and Genesco Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gco#NYSE">GCO</a>) today.
At a current reading of 75, the index moved to the &quot;Extreme Greed&quot; zone on Thursday, versus a prior reading of 74.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
&nbsp;
Read Next: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37533944/over-20m-bet-on-this-healthcare-stock-check-out-these-3-stocks-insiders-are-buying"> Over $20M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying </a>

Investor Sentiment Improves Further, S&P 500 Surges To Fresh High

With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects Genesco Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gco#NYSE">GCO</a>) to report quarterly earnings at $3.04 per share on revenue of $705.66 million before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Genesco shares gained 3% to $30.15 in after-hours trading.
Smith &amp; Wesson Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swbi#NASDAQ">SWBI</a>) reported better-than-expected third-quarter financial results. Smith &amp; Wesson Brands shares surged 7.9% to $14.50 in the after-hours trading session.
Analysts are expecting Algonquin Power &amp; Utilities Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aqn#NYSE">AQN</a>) to have earned 15 cents per share on revenue of $652.95 million for the latest quarter. The company will release earnings before the markets open. Algonquin Power &amp; Utilities shares gained 1.5% to $6.20 in after-hours trading.
Check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
The Gap, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gps#NYSE">GPS</a>) reported stronger-than-expected financial results for its fourth quarter. Gap shares jumped 5.6% to $20.42 in the after-hours trading session.
Analysts expect America&#39;s Car-Mart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crmt#NASDAQ">CRMT</a>) to report a quarterly loss at 65 cents per share on revenue of $350.96 million before the opening bell. America&#39;s Car-Mart shares gained 1.1% to $63.00 in after-hours trading.
Check This Out: <a href="https://www.benzinga.com/news/24/03/37533031/top-3-tech-and-telecom-stocks-that-may-keep-you-up-at-night-this-quarter"> Top 3 Tech And Telecom Stocks That May Keep You Up At Night This Quarter </a>
&nbsp;

Gap, Genesco And 3 Stocks To Watch Heading Into Friday

America's Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) is set to give its latest quarterly earnings report on Friday, 2024-03-08. Here's what investors need to know before the announcement.
Analysts estimate that America's Car-Mart will report an earnings per share (EPS) of $-0.65. 
America's Car-Mart bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $5.08, which was followed by a 3.98% drop in the share price the next day.
Here's a look at America's Car-Mart's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.78</td>
<td>0.98</td>
<td>1.13</td>
<td>0.49</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-4.30</td>
<td>0.63</td>
<td>0.32</td>
<td>0.23</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.0%</td>
<td>-3.0%</td>
<td>8.0%</td>
<td>4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1709820044_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of America's Car-Mart were trading at $60.75 as of March 06. Over the last 52-week period, shares are down 24.53%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CRMT/earnings">To track all earnings releases for America's Car-Mart visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

America's Car-Mart's Earnings Outlook

<h3>Gainers</h3>
<ul>
<li>Nerdy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRDY#NYSE">NRDY</a>) stock increased by 5.0% to $2.91 during Tuesday's after-market session. The company's market cap stands at $311.5 million. </li>
<li>Big 5 Sporting Goods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGFV#NASDAQ">BGFV</a>) shares moved upwards by 4.95% to $4.45. The market value of their outstanding shares is at $99.8 million. </li>
<li>Yoshitsu Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKLF#NASDAQ">TKLF</a>) shares increased by 4.7% to $0.24. The company's market cap stands at $10.3 million. </li>
<li>Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXPR#NYSE">EXPR</a>) stock moved upwards by 4.48% to $2.33. The company's market cap stands at $8.7 million. </li>
<li>Rent the Runway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) stock rose 3.91% to $0.38. The company's market cap stands at $26.9 million. </li>
<li>BARK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BARK#NYSE">BARK</a>) shares rose 3.87% to $1.34. The company's market cap stands at $237.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Nordstrom (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) stock fell 9.3% to $18.95 during Tuesday's after-market session. The market value of their outstanding shares is at $3.0 billion. As per the news, the Q4 earnings report came out today. </li>
<li>America's Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) stock decreased by 7.3% to $57.99. The market value of their outstanding shares is at $370.7 million. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) shares fell 6.39% to $0.24. The market value of their outstanding shares is at $5.4 million. </li>
<li>Visionary Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GV#NASDAQ">GV</a>) shares fell 5.32% to $0.17. The company's market cap stands at $8.8 million. </li>
<li>American Public Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) stock decreased by 3.35% to $10.99. The market value of their outstanding shares is at $195.4 million. As per the press release, Q4 earnings came out today. </li>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) shares decreased by 3.01% to $4.85. The market value of their outstanding shares is at $53.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APEI

BARK

BGFV

EXPR

FTEL

NRDY

RENT

TKLF

12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session

BIRK

PLCE

TBLT

VSCO

Shares of several retail and apparel companies are trading lower after January CPI data showed a greater-than-expected rise in inflation.

Stephens &amp; Co. analyst Vincent Caintic reiterates America's Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) with a Equal-Weight and maintains $82 price target.

Reiteration

Stephens & Co. Reiterates Equal-Weight on America's Car-Mart, Maintains $82 Price Target

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.
Shares of Rivian Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rivn#NASDAQ">RIVN</a>) fell sharply during Tuesday&rsquo;s session after the company reported delivery and <a href="https://www.benzinga.com/markets/equities/24/01/36452278/why-rivian-automotive-shares-are-tumbling-today">production figures for 2023</a>.
The company produced 17,541 vehicles (vs. 10,020) at its manufacturing facility in Normal, Illinois, and delivered 13,972 cars in the fourth quarter. The recent-quarter delivery was below the third-quarter figure of 15,564 and below analysts&#39; estimate of 14,430, as per Reuters.
Rivian Automotive shares dipped 9.1% to $21.34 on Tuesday.
Here are some other big stocks recording losses in today&rsquo;s session.
<ul>
<li>Corcept Therapeutics Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cort#NASDAQ">CORT</a>) shares dipped 26.3% to $23.93 after the company announced the Court for the District of New Jersey issued a decision that Teva Pharmaceuticals does not infringe any asserted claims of Corcept&#39;s U.S. Patents 10,195,214 and 10,842,800.</li>
<li>Anavex Life Sciences Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avxl#NASDAQ">AVXL</a>) shares tumbled 26.2% to $6.88 after the company provided an update on Rett Syndrome program.</li>
<li>Vertex Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtnr#NASDAQ">VTNR</a>) dipped 20.1% to $2.7069 after the company announced it amended its existing term loan agreement, which provides for an incremental $50 million in borrowings to the company.</li>
<li>JOYY Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yy#NASDAQ">YY</a>) declined 16.2% to $33.27 after the company announced it received a written notice from an affiliate of Baidu purporting to terminate the Share Purchase Agreement, dated Nov. 16, 2020.</li>
<li>GoodRx Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdrx#NASDAQ">GDRX</a>) shares tumbled 15.5% to $5.66 after B of A Securities downgraded the stock from Buy to Underperform and lowered its price target from $8 to $4.5.</li>
<li>Aurora Innovation, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aur#NASDAQ">AUR</a>) shares declined 13.8% to $3.7605 after the company filed for an $850 million mixed securities shelf offering.</li>
<li>ToughBuilt Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tblt#NASDAQ">TBLT</a>) fell 13.5% to $8.86.</li>
<li>Bitdeer Technologies Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btdr#NASDAQ">BTDR</a>) tumbled 12.5% to $8.63.</li>
<li>AST SpaceMobile, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asts#NASDAQ">ASTS</a>) fell 11.4% to $5.34.</li>
<li>Amprius Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ampx#NASDAQ">AMPX</a>) declined 11.2% to $4.70.</li>
<li>MiMedx Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdxg#NASDAQ">MDXG</a>) dipped 10.9% to $7.82 after the company announced it received a Warning Letter from FDA for AXIOFILL. The company also reiterated its outlook for 2023 full year net sales growth and fourth quarter adjusted EBITDA margin.</li>
<li>Pulse Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plse#NASDAQ">PLSE</a>) fell 10.7% to $10.93. Pulse Biosciences filed 510(k) submission with the US FDA for its CellFX nsPFA cardiac clamp.</li>
<li>Fusion Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fusn#NASDAQ">FUSN</a>) declined 10.5% to $8.60.</li>
<li>Savara Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svra#NASDAQ">SVRA</a>) fell 9.7% to $4.24.</li>
<li>PureTech Health plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prtc#NASDAQ">PRTC</a>) dipped 9.6% to $24.79.</li>
<li>VinFast Auto Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>) fell 8.9% to $7.63. VinFast has officially signed agreements with five dealers in four states across the U.S.</li>
<li>America&#39;s Car-Mart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crmt#NASDAQ">CRMT</a>) fell 8% to $69.70. Stephens &amp; Co. downgraded America&#39;s Car-Mart from Overweight to Equal-Weight.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) shares declined 7.7% to $1.6141.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) fell 7.4% to $11.69.</li>
<li>Arm Holdings plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/arm#NYSE">ARM</a>) fell 6.3% to $70.42.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/01/36452122/this-analyst-with-84-accuracy-rate-sees-around-13-upside-in-darden-restaurants-here-are-"> This Analyst With 84% Accuracy Rate Sees Around 13% Upside In Darden Restaurants - Here Are 5 Stock Picks For 2023 From Wall Street&#39;s Most Accurate Analysts</a>

AMPX

ASTS

AVXL

BTDR

CORT

FUSN

GDRX

MDXG

PLSE

PRTC

RIVN

SVRA

VTNR

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday

America's Car-Mart shares are trading lower after Stephens & Co downgraded the stock from Overweight to Equal-Weight.

Stephens &amp; Co. analyst Vincent Caintic downgrades America's Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) from Overweight to Equal-Weight.

Downgrades

Stephens & Co. Downgrades America's Car-Mart to Equal-Weight

Stephens &amp; Co. analyst Vincent Caintic maintains America's Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) with a Overweight and lowers the price target from $135 to $83.

Stephens & Co. Maintains Overweight on America's Car-Mart, Lowers Price Target to $83

River Oaks Capital H2 2023 Letter

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
February triggered a rollercoaster ride through the stock market&rsquo;s twists and turns. Amidst the cacophony of <a href="https://investorplace.com/stock-types/growth-stocks/">growth stocks</a> to sell, three names echo the market with a hint of fundamental caution.



Once labeled castles of value potential, these growth stocks stand at a dangerous crossroads. From the bustling aisles of automotive retail to the lofty heights of aerospace and defense and the promising frontiers of biotechnology, each sector carries its tale of uncertainty.



Discover the allure of growth stocks compared against the backdrop of looming risks. Read more to heed the melody of caution these growth stocks to sell create in February&rsquo;s market moves.



<h2>America&rsquo;s Car-Mart (CRMT)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/01/car-1600-300x169.jpg" alt="the front wheels of a series of cars in a line"><div>Source: lumen-digital / Shutterstock.com</div></div>


A concerning trend exists in America&rsquo;s Car-Mart&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/crmt-stock-quote/">CRMT</a>) net charge-offs. The net charge-offs as a percentage of average finance receivables rose to&nbsp;<a href="https://ir.car-mart.com/news-events/press-releases/news-details/2023/Americas-Car-Mart-Reports-Second-Quarter-2024-Results/default.aspx" target="_blank">7.2% from 5.8%</a>&nbsp;YOY. This significant increase in net charge-offs signifies a deterioration in the credit quality of the company&rsquo;s loan portfolio. Theoretically, when borrowers default on their loans, it leads to write-offs. This directly reduces the company&rsquo;s net income and weakens its position.



Additionally, the ongoing adverse economic phase may lead to higher default rates as consumers struggle to meet financial obligations. Moreover, due to inflation, changes in consumer preferences or purchasing behavior may continue to impact the performance of certain loan segments. For example, shifts towards online shopping or alternative transportation options affect the demand for America&rsquo;s Car-Mart&rsquo;s vehicles and, therefore, the performance of its loan portfolio.



Furthermore, America&rsquo;s Car-Mart adjusted its allowance for credit losses in response to the rising credit losses. A reserve is set aside to cover potential losses from defaulted loans. The company increased the allowance for credit losses sequentially from&nbsp;<a href="https://finance.yahoo.com/news/america-car-mart-inc-nasdaq-132934542.html" target="_blank">23.91% to 26.04%</a>, resulting in a $28 million charge to the provision expense. The increased credit risk within the loan portfolio requires the company to build adequate reserves to absorb potential losses.



Financially, the provision for credit losses directly impacts the company&rsquo;s profitability and capital adequacy. By increasing the provision for credit losses, America&rsquo;s Car-Mart&nbsp;<a target="_blank" href="https://finance.yahoo.com/news/america-car-mart-inc-nasdaq-132934542.html">acknowledges</a>&nbsp;the heightened risk environment and takes proactive measures to protect its financial stability. However, prolonged higher provisions for credit losses can also lower reported earnings in upcoming quarters.



<h2>AerSale (ASLE)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/AER1600-300x169.jpg" alt="image of a plane flying in the sky representing airline stocks"><div>Source: Shutterstock</div></div>


For AerSale (NASDAQ:<a href="https://investorplace.com/stock-quotes/asle-stock-quote/">ASLE</a>), the variability in flight equipment sales affects its performance and valuations. AerSale acknowledges that its quarterly performance tends to be &ldquo;<a href="https://finance.yahoo.com/news/aersale-corporation-nasdaq-asle-q3-222127695.html" target="_blank">lumpy</a>&rdquo; due to the timing of flight equipment sales. This indicates that revenues can vary significantly from one quarter to another, impacting overall performance and stability. In detail, Q3 2023 sales stand at $92.5 million against Q3 2022 sales at $51 million.



While there is sequential growth in sales, the Q3 2023 results trailed internal forecast expectations. This suggests that the company&rsquo;s performance did not meet its projected targets for the period. The gap between actual and projected sales reflects the uncertainty and variability in AerSale&rsquo;s topline projections, affecting its capability to meet investor expectations.



There are potential delays in closing several flight equipment sales slated for Q3, with expectations of some sales rolling into Q4. This delay in revenue recognition impacts the timing of cash inflows and may lead to revenue shifting between quarters. Hence, these deferred shifts in cash flows may continue to impact valuations.



Moreover, gross margin is also impacted by the mix of flight equipment sales. For instance, Q3 2023&rsquo;s gross margin was&nbsp;<a target="_blank" href="https://finance.yahoo.com/news/aersale-corporation-nasdaq-asle-q3-222127695.html">25.4%</a>, while Q3 2022&rsquo;s gross margin was 30.4%. The decline in gross margin from Q3 2022 to Q3 2023 indicates the impact of the mix of flight equipment sales on profitability.&nbsp;



One of the factors contributing to this margin compression is operating expenses, specifically selling, general and administrative (SG&amp;A) expenses. Q3 2023 SG&amp;A expenses increased by&nbsp;<a href="https://d1io3yog0oux5.cloudfront.net/_0c5b4f3dcb00f246e199e3a932ea47e3/aersale/news/2023-11-08_AerSale_Reports_Third_Quarter_2023_96.pdf" target="_blank">$25.4 million</a>&nbsp;compared to SG&amp;A expenses of $24 million (Q3 2022). Overall, this growth momentum in operating expenses may continue to impact the company&rsquo;s bottom line and, as a result, its valuation.



<h2>Annovis Bio (ANVS)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063-300x169.png" alt="Pipette adding fluid to one of several test tubes; biotech NVTA Stock"><div>Source: motorolka / Shutterstock.com</div></div>


Annovis Bio&rsquo;s (NYSE:<a href="https://investorplace.com/stock-quotes/anvs-stock-quote/">ANVS</a>)&nbsp;<a href="https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?airportNewsID=b5ae14cd-0b6c-4da3-a0e7-e57e1603baef" target="_blank">postponement</a>&nbsp;of the Phase III study data release for buntanetap in Parkinson&rsquo;s disease reflects a fundamental weakness. This may hinder the company&rsquo;s rapid growth potential. The delay was based on ongoing data-cleaning moves to ensure the accuracy and reliability of the study results. While the focus on data integrity is vital, the postponement raises concerns regarding the company&rsquo;s capability to hit timelines.



Additionally, Phase III trials are a critical stage where the efficacy and safety of a drug are tested on a larger scale. This serves as a vital point for regulatory submissions and market approval. Any delays in the completion or announcement of Phase III study results breed a considerable downside risk for valuation.



Moreover, the decision to postpone (initiate set for&nbsp;<a href="https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?airportNewsID=b5ae14cd-0b6c-4da3-a0e7-e57e1603baef" target="_blank">January 2024</a>) the data release suggests complexities encountered during the data cleaning process. These delays in study timelines may erode market sentiment for Annovis Bio&rsquo;s execution capabilities. This loss of developmental credibility may have long-term repercussions, impacting the company&rsquo;s ability to attract further funding, form strategic partnerships and sustain value growth. Thus, this has been integrated into the stock price since the beginning of 2024.



Furthermore, the short interest rate on Annovis Bio&rsquo;s stock is at nearly&nbsp;<a target="_blank" href="https://seekingalpha.com/symbol/ANVS">13%</a>. This delay may continue to create opportunities for short-sellers to capitalize on this uncertainty and volatility. These short-term fluctuations in the stock price and variability in the developmental path logically undermine long-term value creation.



Finally, the delay in the Phase III study data announcement impacted Annovis Bio&rsquo;s competitive edge. Hence, the delay in study data can cause a delay in the drug&rsquo;s push to market, which will continue to adversely impact Annovis Bio&rsquo;s market share and value potential.



On the date of publication, Yiannis Zourmpanos did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT766413">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/02/3-growth-stocks-to-sell-in-february-before-they-bottom/">3 Growth Stocks to Sell in February Before They Bottom</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

3 Growth Stocks to Sell in February Before They Bottom

America's Car-Mart, Inc. (CRMT) stock is down -26.23% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserverâ€&#x2122;s proprietary ranking system, gives CRMT stock a score of  19 out of a possible 100. That rank is chiefly influenced by a long-term technical score of 12. CRMT's rank

America's Car-Mart, Inc. (CRMT) Stock Climbs 2.74% This Week; Should You Buy?

Catalyst Watch: Jobs report, Powell treks to Congress, Target earnings and major tech conference

Earnings week ahead: NIO, Costco, Target, JD.com, CrowdStrike, DocuSign and more

Magnolia Oil & Gas to join S&P SmallCap 600

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
As the saying goes, what goes up must come down. This adage holds true for three stocks. With the market seemingly inflated, it&rsquo;s vital to identify the warning signs of potential crashes before they occur. These stocks hold solid weaknesses and red flags that could signal an imminent burst in their respective bubbles.



The first one grapples with declining retail unit sales and deteriorating credit quality. The company wrestles with declining sales and mounting credit risks. The second one faces volatility in flight equipment sales and uncertain revenue patterns. It is reliant on the unpredictable currents of flight equipment sales. 



Meanwhile, the third experienced setbacks in the clinical trial data release, raising doubts about its growth. Its growth looms around the release of critical clinical trial data. By identifying these vulnerabilities early on, risks can be minimized, and portfolios can be protected.



Read more to dissect the fundamentals behind these stocks. Understanding when to unload these stocks may safeguard investments as the pressure mounts and uncertainties loom.



<h2>America&rsquo;s Car-Mart (CRMT)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/08/auto-stocks-1600-300x169.jpg" alt="An angled side view of a row of parked cars. automotive stock picks"><div>Source: lumen-digital / Shutterstock.com</div></div>America&rsquo;s Car-Mart (NASDAQ:<a href="https://investorplace.com/stock-quotes/crmt-stock-quote/">CRMT</a>) is attached to several fundamental downsides. These downsides breed severe issues with its valuation growth. For instance, in Q2 fiscal 2024, retail unit sales&nbsp;<a href="https://ir.car-mart.com/news-events/press-releases/news-details/2023/Americas-Car-Mart-Reports-Second-Quarter-2024-Results/default.aspx" target="_blank">decreased by 4.6%</a>&nbsp;year-over-year (YoY). A decline in retail unit sales suggests prevailing adversities in attracting clients and capturing market demand trends. This weakness is bred from numerous factors, such as economic conditions, affordability adversities, or operational edge.



Additionally, net charge-offs as a percentage of average finance receivables boosted to 7.2% in Q2 from 5.8% in Q2 2023. The considerable increase in net charge-offs suggests deteriorating credit quality. In short, there is an increase in default rates among customers. This trend could indicate adversity in managing credit risk, potentially leading to financial losses and hindering growth.



Furthermore, the allowance for credit losses increased from&nbsp;<a href="https://finance.yahoo.com/news/america-car-mart-inc-nasdaq-132934542.html" target="_blank">23.91% to 26.04%</a>&nbsp;sequentially. This is resulting in a $28 million charge to the provision. The considerable increase in the allowance for credit losses reflects management&rsquo;s recognition of higher credit risk and potential losses. This weakness could impact the bottom line and cash flow, limiting the company&rsquo;s capability to invest in growth initiatives.



Moreover, the gross margin percentage declined&nbsp;<a target="_blank" href="https://finance.yahoo.com/news/america-car-mart-inc-nasdaq-132934542.html">sequentially by 0.3%</a>. Despite YoY improvements, this sequential decline in gross margin suggests adversity in maintaining profitability under ongoing fluctuating sales volumes and cost pressures. This weakness is based on inefficiencies in cost management or pricing strategies, potentially impacting consolidated performance.



Finally, implementing the new loan origination system (LOS) led to operational issues and impacted sales volumes. Moving forward, operational adversities associated with the new LOS could disrupt sales processes, client acquisition, and underwriting efficiency.&nbsp;



<h2>AerSale (ASLE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/12/aerospace-300x169.jpg" alt="a private plane inside a hangar is prepared for a flight. represent aerospace stocks"><div>Source: Shutterstock</div></div>AerSale&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/asle-stock-quote/">ASLE</a>) top and bottom lines heavily depend on the timing and volume of flight equipment sales. While the company had a considerable boost in revenue and adjusted EBITDA, much of this growth is based on&nbsp;<a href="https://d1io3yog0oux5.cloudfront.net/_5f2acfe011e21079e27f2fd4e7547218/aersale/news/2023-11-08_AerSale_Reports_Third_Quarter_2023_96.pdf" target="_blank">higher flight equipment sales</a>&nbsp;in Q3 2023 compared to 2022. However, flight equipment sales may fluctuate considerably from quarter to quarter, leading to a lumpy revenue pattern.



Furthermore, the reliance on the pacing of flight equipment sales injected high uncertainty and unpredictability into AerSale&rsquo;s performance. Several flight equipment sales were projected for Q3 2023 but were delayed and expected to&nbsp;<a target="_blank" href="https://finance.yahoo.com/news/aersale-corporation-nasdaq-asle-q3-222127695.html">close in Q4</a>. This dependency on the timing of sales may create adversity in constantly meeting revenue and profitability targets.



Fundamentally, the weakness in the timing of flight equipment sales is exacerbated by external market factors, such as fluctuations in the freight market and shifts in consumer demand. The softening of the air cargo market and tightening financial market conditions (Fed&rsquo;s higher for longer) could prolong the sales cycle of certain aircraft inventory. As a result, this may continue to impact AerSale&rsquo;s capability to realize revenue in a projected manner. For instance, while Q3 2023 saw a considerable boost in revenue (<a href="https://finance.yahoo.com/news/aersale-corporation-nasdaq-asle-q3-222127695.html" target="_blank">$92.5 million</a>) compared to Q3 2022 ($51 million), this growth was primarily based on higher flight equipment sales.



As a chain reaction, AerSale&rsquo;s stability issues may impact its capability to service debt obligations. Revenue volatility could affect the company&rsquo;s ability to derive sufficient cash flows, leading to delays in meeting regular interest payments and predetermined principal repayments (on outstanding debt). Hence, this could lead to credit rating downgrades or increased borrowing costs.



<h2>Annovis Bio (ANVS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600-300x169.png" alt="Biotechnology stocks, biomedical stocks"><div>Source: aslysun / Shutterstock.com</div></div>Annovis Bio (NYSE:<a href="https://investorplace.com/stock-quotes/anvs-stock-quote/">ANVS</a>) has a&nbsp;<a href="https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?airportNewsID=b5ae14cd-0b6c-4da3-a0e7-e57e1603baef" target="_blank">delay in the release</a>&nbsp;of clinical trial data, particularly for the Phase III study of &lsquo;buntanetap&rsquo; in Parkinson&rsquo;s disease. Meanwhile, since the specific duration of the delay is not yet clear, the initial timeline set for the end of January 2024 was not met. This delay could have considerable implications for the company&rsquo;s growth potential.



Given its advanced stage, the Phase III trial for &lsquo;buntanetap&rsquo; likely involved many patients. A Phase II/III study in Alzheimer&rsquo;s disease was completed involving 353 initially enrolled patients, out of which&nbsp;<a href="https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?airportNewsID=c090280b-5022-42a0-9387-95bfb2b742af" target="_blank">327 concluded</a>&nbsp;the trial successfully. Similarly, the Phase III trial in Parkinson&rsquo;s disease would likely involve a comparable or larger number of patients.



The delay in data release also suggests potential adversity in meeting previously set timelines. The postponement indicates a deviation from this expectation. This could lead to uncertainty and negative market sentiment, impacting the company&rsquo;s stock price and overall market perception.



Moreover, delays in data release could lead to regulatory scrutiny and delays in the approval process for Buntanetap. Regulatory agencies typically require comprehensive data analysis and validation before approving new drug candidates. Any delays in this process could prolong the time to market for Annovis Bio&rsquo;s products, impacting revenue generation and market penetration.



Finally, the company remains blinded to the data (<a href="https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?airportNewsID=b5ae14cd-0b6c-4da3-a0e7-e57e1603baef" target="_blank">still cleaning</a>), indicating that statistical analysis still needs to be performed sharply. Statistical analysis is vital in interpreting clinical trial results and determining the efficacy and safety of investigational drugs. Therefore, Annovis Bio&rsquo;s need for meticulous data cleaning suggests potential data quality or consistency adversities, necessitating rigorous statistical methods to ensure accurate interpretation.



On the date of publication, Yiannis Zourmpanos did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/03/sell-signal-3-stocks-to-unload-before-the-bubble-bursts/">Sell Signal: 3 Stocks to Unload Before the Bubble Bursts</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Sell Signal: 3 Stocks to Unload Before the Bubble Bursts

America's Car-Mart GAAP EPS of -$1.34, revenue of $299.6M

America's Car-Mart, Inc. (CRMT) reported less than expected earnings this morning for Q3 2024. America's Car-Mart's earnings came in at an EPS loss of $1.34 per share, 106% lower than estimates for an EPS loss of $0.65 per share. The firm's earnings are down 683% since reporting $0.23 per share in the same period a year ag

America's Car-Mart Up 17.06% To $72.93 After Earnings Miss

America's Car-Mart, Inc. (CRMT) Q3 2024 Earnings Call Transcript

AAPL

ACIU

AMZN

ANTX

ANVS

APPS

ARCH

AVAV

AVGO

BFCC

BILI

BITF

BKCC

BKNG

BYND

CARA

CCSI

CDMO

CERS

CGEN

CHPT

CHRS

CIEN

CRNC

CRWD

CZBS

DOCU

EVGO

FIZZ

FORR

FTLF

FWRG

GDDY

GEVO

GLXZ

GMVHF

GOOG

GOOGL

GTLB

HLIT

IDEX